The influenza diagnostics market was valued at USD 946.9 million in 2023, which will rise to a total value of USD 1,603.1 million by 2030, powering at a compound annual growth rate of 7.9% by the end of this decade.
The necessity for influenza diagnosis solutions will rise because of the snowballing occurrence of chronic illnesses, numerous of which are deteriorated by the flu; rising elderly populace, and growing government actions to monitor the disease spread. The growth of tech sophisticated diagnostic tools for the infection is an additional key driver of the industry.
The growing occurrence of influenza at the global level has encouraged the launch of research and development initiatives to advance the detection and treatment. Most of the research is directed at making quicker and more-accurate diagnostic tools for flu viruses.
The test kits and reagents category was the leader of the pack with a share of 60% in 2023. This has a lot to do with the substantial incidence of communicable diseases and rising consciousness with regards to their early diagnosis.
The compensations of test kits, such as their easy convenience at retail stores, pharmacies, and online distribution channels without the requirement for a prescription, ease of use, fast results, and affordability, will drive the growth of the category.
With the usage of over-the-counter test kits, anxieties about spreading the flu are eliminated, as they allow one to get tested in separation, without coming near other individuals, who may be carriers. Moreover, POC testing also removes the necessity for healthcare professionals, reducing expenses because of their user-friendliness.
Also, the instruments category will grow the fastest at a rate of 8.3% in the influenza diagnostics market, by the end of this decade. This is credited to the increasing healthcare spending globally, resulting in a surge in the count of hospitals and diagnostic centers, therefore powering the requirement for the instruments used for detecting the existence of the pathogen.
Moreover, the continuing research studies and developing technologies are the main contributors. Furthermore, as a result of their sensitivity and specificity, they offer higher reliability than test kits, fueling their use quickly.
It is because of the significant increase in the number of government screening programs all over the world, the demand for influenza diagnostics solutions will be on the rise. This will be trending in the near future as well.
